Midcareer Transitions: Teaching
My father was an elementary school teacher who eventually became an elementary school principal, a position that he retired from about 15 years ago. As you might imagine, education was an important part of the lives of my three siblings and me. Like my father, three of four of us eventually pursued careers in education: my sister teaches art to high school students in California; my brother is a professor in the Department of Microbiology at the University of Vermont and I have been a science educator for most of my adult life.
When I first entered graduate school in the Department of Bacteriology at the University of Wisconsin-Madison, I intended to pursue a teaching career at a small liberal arts institution. My career goals changed during my graduate school experiences, and ultimately I chose to pursue a career in academic research rather than teaching. Despite that decision, my first and perhaps only love has always been teaching. Ironically, it was my love of teaching that prevented me from winning tenure at the University Of Miami School Of Medicine. While I have reinvented myself no fewer than 10 times during my admittedly circuitous career path, the one common and constant element that links together some of my seemingly disparate career choices has been my love of teaching.
No matter what the experts may say, there is no middle ground in teaching—you either love it or hate. Put simply, there are those who were born to teach and others who were not!
When I give my Alternate Careers for PhDs talk to graduate and postdoctoral fellows who are looking for career options, I always mention teaching. Not surprisingly, I wax romantically about how noble a profession teaching is and the acute need for qualified science teachers. However, I always temper my remarks by emphasizing that “unless you are passionate about teaching, then becoming a teacher may not be an appropriate career choice. In other words, unless you are “all in” you never be an effective teacher. To that end, I came across an article in this Sunday’s New York Times by Peter Wilson; a former executive who decided to eschew a successful public relations career in his mid-30s to become a middle school English teacher.
If after reading Peter's story, you find yourself energized or “moved” by his story, then I believe that you possess the “right stuff” to pursue a career in education. As the old Nike ads urge: “Just Do It!”
Hat tip to Peter Wilson!
Until next time...
Good Luck and Good Job Hunting!!!!!
Despite the announcement late last week in the London Sunday Times that
Let’s face it; scientists aren’t generally regarded as being funny. While I have met several very funny researchers during my almost 35 year career, the vast majority of my colleagues have been mostly serious and, at times, difficult to amuse; especially when things weren't going so well in the lab.
Ed Silverman, over at the newly reinvigorated Pharmalot Blog,
I just returned from the
e-Patients Connections 2009
The Public Library of Science (PLOS) announced that it has launched a new website called PLOS Currents that is intended to serve as a vehicle for the rapid publication of scientific research and new ideas and themes. Not surprisingly, the first theme for PLOS Currents is influenza. On his
BioCrowd co-founder,
During my recent trip to Vermont and Woodstock, NY I had several conversations about Twitter. Surprisingly, I was being asked to explain Twitter to my nephews, both of whom are in their early 20s and to family friends who are in their late 40s and beyond. Also, at several recent science career fairs that I attended many graduate students and postdocs had never heard of Twitter or it they had, they don’t use it. Initially, this was puzzling but after considering the most recent Twitterverse demographics –I think the average age of Twitter users is around 35 to 40—it made more sense to me.
For those of you interested in the Canadian biotechnology scene I want to mention a good resource that I came across recently. The Canadian BioTechnologist 2.0 Blog (
This morning, while doing my usual Twitter review, I came across a tweet from the
For the past decade or so, I have worked as a career counselor at national scientific meetings where I present seminars about resume writing, interviewing techniques and other career related issues. About two years ago, I started to hear about the fierce competition for H-1 and J-1 visas that foreign students must obtain to remain in the US to continue their studies and research. Many of the foreign students that I talked with sounded more like immigration lawyers than graduate students or postdocs—I was amazed at how well informed they were about visa availability and the changes and loopholes in US immigration law that can be exploited to obtain visas.
The compensation packages for CEOs of many publicly held companies have recently, (for obvious reasons), come under intense scrutiny. This has spilled over to the chief executive offices of many not-for-profit organizations including private colleges and universities. While the compensation packages for most university presidents and administrators are substantial in many instances, there are a few university employees who sometimes earn substantially more.
Vincent Racaniello
Did you know that the top ten pharmaceutical companies in the world spent close to $50 billion dollars last year on R&D? That sum could be used to purchase the entire US biotechnology industry except for the five largest companies—Genentech, Amgen, Gilead Genzyme and Celgene. Further, pharma’s R&D budget is about 4 times the R&D budget of all of the US biotechnology companies combined. According to a
For the past 60 years, American science was second to none. However, the US is perilously close to losing that distinction. Put simply, American science, like its economy, is in free fall.
The
Genzyme Corp announced yesterday


